Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK

By Jansen Jeroen P.   Pellissier James   Choy Ernest H.   Ostor Andrew   Nash Julian T.   Bacon Paul   Hunsche Elke  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3069-3078

Informa Healthcare

Access to resources Recommend Favorite

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis

By Ramey Dena R.   Watson Douglas J.   Yu Chang   Bolognese James A.   Curtis Sean P.   Reicin Alise S.  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE^−/− mice

By Metzner Julia   Popp Laura   Marian Claudiu   Schmidt Ronald   Manderscheid Christine   Renne Christoph   Fisslthaler Beate   Fleming Ingrid   Busse Rudi   Geisslinger Gerd   Niederberger Ellen  

Journal of Molecular Medicine, Vol. 85, Iss. 6, 2007-06 ,pp. : 623-633

Springer Publishing Company

Access to resources Recommend Favorite

Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension

By Morrison Alan   Ramey Dena Rosen   van Adelsberg Janet   Watson Douglas J.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2395-2404

Informa Healthcare

Access to resources Recommend Favorite

Gastroprotection in patients prescribed non-selective NSAIDs, and the risk of related hospitalization

By Koncz T. A.   Lister S. P.   Makinson G. T.  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3405-3412

Informa Healthcare

Access to resources Recommend Favorite